Serum Total Adiponectin and its Relationship with Glycemic Control ad Markers of Lipoprotein Metabolism in Nigerians with Type 2 Diabetes Mellitus

被引:0
作者
Okoro, Ngozi [1 ]
Okpara, Henry [2 ]
Azinge, Elaine [3 ]
Builders, Modupe [4 ]
机构
[1] Bingham Coll Med & Hlth Sci, Dept Chem Pathol, Jos, Nigeria
[2] Univ Calabar, Dept Chem Pathol, Calabar, Nigeria
[3] Lagos Univ, Teaching Hosp, Dept Clincal Pathol, Lagos, Nigeria
[4] Bingham Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Jos, Nigeria
关键词
Adiponectin; Metabolic control; Type; 2; diabetes; Nigeria; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; PLASMA ADIPONECTIN; HYPOADIPONECTINEMIA; ASSOCIATION; EXPRESSION; OBESITY; RISK;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Adiponectin is a hormone that is mostly and abundantly produced by the adipocytes and directly sensitizes the body to insulin. Due to the increasing prevalence of Type 2 diabetes mellitus (T2DM) in sub-Saharan Africa, serum adiponectin has attracted much attention because of its anti-diabetic, anti-atherogenic and anti-inflammatory effects. Therefore, the aim of this study was to determine the relationship between serum adiponectin and the metabolic control of plasma glucose and lipids among type 2 diabetic patients. Methods: This was a cross-sectional study of Type 2 diabetic adult Nigerian males and females with age and sex-matched non-diabetic controls. Fasting serum total adiponectin, triglyceride (TG), total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), plasma glucose (FPG) and glycated haemoglobin (HbA1C) were determined. Dyslipidemia was defined based on the third report of National Cholesterol Education Programme, Adult Treatment Panel III (NCEPATP III). Statistical analyses were performed using SPSS version 19 and p<0.05 was considered to be significant. Results: One hundred and eighty subjects (106 females and 74 males) were recruited for the study. Type 2 diabetes mellitus subjects were 110 (61.1%) with mean age of 54.5yrs while healthy non-diabetic controls were 70 (38.9%) with the mean age of 51.8yrs. The prevalence of hypoadiponectinemia T2DM subjects was (82.4%) with a (mean value of 10.71 +/- 1.85ng/ml) and 17.6% among the controls (mean value 21.14 +/- 1.98ng/ml) after log transformation. The correlation coefficients between serum adiponectin and lipid profile parameters, HbA1C and FPG among the subjects were: TG (r=-0.022, p=0.045), TC (r=-0.014, p=0.114), HDL-C (r=0.01, p=0.808), LDL-C (r=-0.007, p=0.267), HbA1C (r=-0.24, p=0.001), FPG (r=-0.22, p=0.003). There were weak but significant negative correlations of adiponectin with FPG and HbA1C. There were weak negative correlations between serum adiponectin and the lipid profile parameters except HDL-C. Conclusion: Serum adiponectin level was significantly lower among type 2 diabetic Nigerians than their control (non-diabetic) counterparts.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 32 条
  • [1] Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function
    Bacha, F
    Saad, R
    Gungor, N
    Arslanian, SA
    [J]. DIABETES CARE, 2004, 27 (02) : 547 - 552
  • [2] ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism
    Berg, AH
    Combs, TP
    Scherer, PE
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) : 84 - 89
  • [3] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [4] Effect of ovarian hormones on serum adiponectin and resistin concentrations
    Chalvatzas, Nektarios
    Dafopoulos, Konstantinos
    Kosmas, Georgios
    Kallitsaris, Athanasios
    Pournaras, Spyros
    Messinis, Ioannis E.
    [J]. FERTILITY AND STERILITY, 2009, 91 (04) : 1189 - 1194
  • [5] Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population - The Funagata study
    Daimon, M
    Oizumi, T
    Saitoh, T
    Kameda, W
    Hirata, A
    Yamaguchi, H
    Ohnuma, H
    Igarashi, M
    Tominaga, M
    Kato, T
    [J]. DIABETES CARE, 2003, 26 (07) : 2015 - 2020
  • [6] Relationship of serum adiponectin with blood lipids, HbA1c, and hs-CRP in type II diabetic postmenopausal women
    Goodarzi, Mohammad Taghi
    Babaahmadi-Rezaei, Hossein
    Kadkhodaei-Eliaderani, Manizheh
    Haddadinezhad, Shahram
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2007, 21 (03) : 197 - 200
  • [7] Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population
    Hara, K
    Boutin, P
    Mori, Y
    Tobe, K
    Dina, C
    Yasuda, K
    Yamauchi, T
    Otabe, S
    Okada, T
    Eto, K
    Kadowaki, H
    Hagura, R
    Akanuma, Y
    Yazaki, Y
    Nagai, R
    Taniyama, M
    Matsubara, K
    Yoda, M
    Nakano, Y
    Kimura, S
    Tomita, M
    Kimura, S
    Ito, C
    Froguel, P
    Kadowaki, T
    [J]. DIABETES, 2002, 51 (02) : 536 - 540
  • [8] Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance
    Hoffstedt, J
    Arvidsson, E
    Sjölin, E
    Wåhlén, K
    Arner, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1391 - 1396
  • [9] Ethnic differences in adiponectin levels
    Hulver, MW
    Saleh, O
    MacDonald, KG
    Pories, WJ
    Barakat, HA
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (01): : 1 - 3
  • [10] Kissbah AH, 2000, P NATL ACAD SCI USA, V97, P14